Drugs / ATR04-484
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06830863 | Aug 2025 → Jan 2027 expected | — | Azitra Inc. | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ATR04-484 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06830863 ↗ |
| Modality | Other / unclassified | “recombinant live biotherapeutic product (rLBP)” NCT06830863 ↗ |
| Route | Topical | “in an ointment formulation for topical use” NCT06830863 ↗ |